Sands, B.E.; Peyrin-Biroulet, L.; Schreiber, S.; Danese, S.; Armuzzi, A.; Buisson, A.; Fumery, M.; Dignass, A.; Powell, N.; Kennedy, N.A.;
et al. Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis. J. Clin. Med. 2025, 14, 4419.
https://doi.org/10.3390/jcm14134419
AMA Style
Sands BE, Peyrin-Biroulet L, Schreiber S, Danese S, Armuzzi A, Buisson A, Fumery M, Dignass A, Powell N, Kennedy NA,
et al. Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2025; 14(13):4419.
https://doi.org/10.3390/jcm14134419
Chicago/Turabian Style
Sands, Bruce E., Laurent Peyrin-Biroulet, Stefan Schreiber, Silvio Danese, Alessandro Armuzzi, Anthony Buisson, Mathurin Fumery, Axel Dignass, Nick Powell, Nicholas A. Kennedy,
and et al. 2025. "Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis" Journal of Clinical Medicine 14, no. 13: 4419.
https://doi.org/10.3390/jcm14134419
APA Style
Sands, B. E., Peyrin-Biroulet, L., Schreiber, S., Danese, S., Armuzzi, A., Buisson, A., Fumery, M., Dignass, A., Powell, N., Kennedy, N. A., Zeissig, S., Kwon, T., Kim, S., Nam, K., & Hanauer, S. B.
(2025). Efficacy and Safety of Infliximab and Vedolizumab Maintenance Therapy in Patients with Crohn’s Disease and Ulcerative Colitis: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 14(13), 4419.
https://doi.org/10.3390/jcm14134419
